1. Home
  2. NUVB vs BBSI Comparison

NUVB vs BBSI Comparison

Compare NUVB & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • BBSI
  • Stock Information
  • Founded
  • NUVB 2018
  • BBSI 1965
  • Country
  • NUVB United States
  • BBSI United States
  • Employees
  • NUVB N/A
  • BBSI N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • NUVB Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • NUVB Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • NUVB 959.2M
  • BBSI 1.1B
  • IPO Year
  • NUVB N/A
  • BBSI 1993
  • Fundamental
  • Price
  • NUVB $2.58
  • BBSI $44.37
  • Analyst Decision
  • NUVB Strong Buy
  • BBSI Buy
  • Analyst Count
  • NUVB 6
  • BBSI 3
  • Target Price
  • NUVB $7.00
  • BBSI $41.67
  • AVG Volume (30 Days)
  • NUVB 2.8M
  • BBSI 98.1K
  • Earning Date
  • NUVB 02-27-2025
  • BBSI 02-26-2025
  • Dividend Yield
  • NUVB N/A
  • BBSI 0.70%
  • EPS Growth
  • NUVB N/A
  • BBSI 10.06
  • EPS
  • NUVB N/A
  • BBSI 1.89
  • Revenue
  • NUVB $2,162,000.00
  • BBSI $1,116,393,000.00
  • Revenue This Year
  • NUVB N/A
  • BBSI $8.11
  • Revenue Next Year
  • NUVB $369.72
  • BBSI $7.27
  • P/E Ratio
  • NUVB N/A
  • BBSI $23.41
  • Revenue Growth
  • NUVB N/A
  • BBSI 4.87
  • 52 Week Low
  • NUVB $1.52
  • BBSI $27.06
  • 52 Week High
  • NUVB $4.16
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 45.02
  • BBSI 62.19
  • Support Level
  • NUVB $2.47
  • BBSI $40.92
  • Resistance Level
  • NUVB $2.77
  • BBSI $44.97
  • Average True Range (ATR)
  • NUVB 0.23
  • BBSI 1.00
  • MACD
  • NUVB -0.04
  • BBSI 0.14
  • Stochastic Oscillator
  • NUVB 13.30
  • BBSI 85.19

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: